Clinical Effects of Meglumine Adenosine Cyclophosphate for Treatment of Heart Failure in Ischemic Cardiomyopathy

He Tao,Tao Jianhong,Liu Mingjiang,Li Gang
DOI: https://doi.org/10.3969/j.issn.1006-4931.2007.09.031
2007-01-01
Abstract:Objective To evaluate the clinical effect of megumine adenosine cyclophosphate in heart failure of ischemic cardiomyopathy with 6 min walk test and ultrasonic cardiogram.Methods A total of 89 patients were divided into two groups randomly:the control group (44 cases) received the routine treatment and the treated group (45 cases) received the routine treatment and intravenous injection of meglumine adenosine cyclophosphate,120 mg every time,once daily.LVD,EF,6 min walk test,etc.were evaluated before the treatment and after 3 months of treatment in two groups.Results LVD,EF,6 min walk test,etc.were markedly improved in the treated group than in the control group.Conclusion A combination of meglumine adenosine cyclophosphate and routine treatment can improve the systolic function of the heart and increase the exercise tolerance.
What problem does this paper attempt to address?